SMTL ID : 6moa.1

C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.27 Å

Oligo State

monomer

Ligands

1 x JW4: 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole(Non-covalent)

JW4.1: 13 residues within 4Å: Chain A: W.25, P.26, F.27, V.31, L.36, L.38, C.80, Y.83, N.84, H.88, D.89, V.90, M.93 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.25, A:W.25, A:W.25, A:P.26, A:F.27, A:L.36, A:L.38, A:Y.83, A:V.90 Hydrogen bonds: A:N.84 Water bridges: A:P.26, A:P.30, A:C.80 pi-Stacking: A:H.88

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 3 residues within 4Å: Chain A: Y.23, M.93, K.96 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.96, A:K.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sperandio, D. et al., Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg. Med. Chem. (2019)

Release Date

2019-01-23

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2